Loading clinical trials...
Loading clinical trials...
Recent studies have shown beneficial effects of sildenafil in patients with single ventricle congenital heart disease. The purpose of this study is to determine whether Bosentan, a drug with similar effects, will have similar benefit in this patient population.
Patients enrolled in the study will take Bosentan. Baseline and follow up measurements will be collected then analyzed.
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
No
UCLA Medical Center
Los Angeles, California, United States
Start Date
May 1, 2010
Primary Completion Date
March 1, 2013
Completion Date
March 1, 2013
Last Updated
February 27, 2015
10
ACTUAL participants
Bosentan
DRUG
Lead Sponsor
University of California, Los Angeles
Collaborators
NCT05647213
NCT07042334
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions